Intercurrent Factors Associated with the Development of Open-Angle Glaucoma in the European Glaucoma Prevention Study

American Journal of Ophthalmology

Volumn 144, Issue 2, 2007, Pages

  Miglior, Stefano ^a   Torri, Valter ^b   Zeyen, Thierry ^c   Pfeiffer, Norbert ^d   Vaz, Jose Cunha ^e   Adamsons, Ingrid ^f  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^c UNIVERSITY OF LEUVEN   (Belgium)

^d JOHANNES GUTENBERG UNIVERSITY   (Germany)

^e UNIVERSITY OF COIMBRA   (Portugal)

^f MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIURETIC AGENT; DORZOLAMIDE; PLACEBO;

AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORNEA THICKNESS; DOUBLE BLIND PROCEDURE; FOLLOW UP; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; OPEN ANGLE GLAUCOMA; OPTICAL DISK; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; VISUAL FIELD;

EID: 34447645668     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2007.04.040     Document Type: Article

References (44)

1. Anderson D.R. Glaucoma: the damage caused by pressure. XLVI Edward Jackson Memorial Lecture. Am J Ophthalmol 108 (1989) 485-495
2. American Academy of Ophthalmology. Primary open-angle glaucoma. Preferred practice pattern (2005), American Academy of Ophthalmology, San Francisco
3. Sommer A., Tielsch J.M., Katz J., et al. Relationship between intraocular pressure and primary open-angle glaucoma among white and black Americans: the Baltimore Eye Survey. Arch Ophthalmol 109 (1991) 1090-1095
4. Tielsch J.M., Katz J., Sommer A., et al. Hypertension, perfusion pressure, and primary open- angle glaucoma. A population-based assessment. Arch Ophthalmol 113 (1995) 216-221
5. Leske C., Connell A.M., Wu S.Y., et al. Risk factors for open-angle glaucoma: the Barbados Eye Study. Arch Ophthalmol 113 (1995) 918-924
6. Leske M.C., Connell A.M.S., Wu S.-Y., et al. Incidence of open-angle glaucoma: the Barbados Eye Study. Arch Ophthalmol 119 (2001) 89-95
7. Tielsch J.M., Katz J., Sommer A., et al. Family history and risk of primary open-angle glaucoma: the Baltimore Eye Survey. Arch Ophthalmol 112 (1994) 69-73
8. Bonomi L., Marchini G., Marraffa M., et al. Vascular risk factors for primary open-angle glaucoma: the Egna-Neumarkt Study. Ophthalmology 107 (2000) 1287-1293
9. Leske M.C., Wu S.-Y., Nemesure B., et al. Incident open-angle glaucoma and blood pressure. Arch Ophthalmol 120 (2002) 954-959
10. Kass M.A., Heuer D.K., Higginbotham E.J., et al. The Ocular Hypertension Treatment Study. A randomized trial determines that topical hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 120 (2002) 701-713
11. The European Glaucoma Prevention Study Group. Results of the European Glaucoma Prevention Study. Ophthalmology 112 (2005) 366-375
12. Gordon M.O., Beiser J.A., Brandt J.D., et al. The Ocular Hypertension Treatment Study. Baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol 120 (2002) 714-720
13. The European Glaucoma Prevention Study Group. Predictive factors for open-angle glaucoma among patients with ocular hypertension in the European Glaucoma Prevention Study. Ophthalmology 114 (2007) 3-9
14. Bengtsson B., and Heijl A. A long-term prospective study of risk factors for glaucomatous visual field loss in patients with ocular hypertension. J Glaucoma 14 (2005) 135-138
15. Nouri-Mahdavi K., Hoffman D., Coleman A.L., et al. Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study. Ophthalmology 111 (2004) 1627-1635
16. Budenz D.L., Anderson D.R., Feuer W.J., et al. Detection and prognostic significance of optic disc hemorrhages during the Ocular Hypertension Treatment Study. Ophthalmology 113 (2006) 2137-2143
17. Langman M.J., Lancashire R.J., Cheng K.K., et al. Systemic hypertension and glaucoma: mechanisms in common and co-occurrence. Br J Ophthalmol 89 (2005) 960-963
18. The European Glaucoma Prevention Study Group. The European Glaucoma Prevention Study design and baseline description of the participants. Ophthalmology 109 (2002) 1612-1621
19. Brandt J.D., Beiser J.A., Kass M.A., et al. Central corneal thickness in the Ocular Hypertension Treatment Study (OHTS). Ophthalmology 108 (2001) 1779-1788
20. Bourget P., and Delouis J.M. Review of a technique for the estimation of area under the concentration curve in pharmacokinetic analysis. [France]. Therapie 48 (1993) 1-5
21. The Ocular Hypertension Treatment Study Group, and European Glaucoma Prevention Study Group. Validated prediction model for the development of primary open-angle glaucoma in individuals with ocular hypertension. Ophthalmology 114 (2007) 10-19
22. Heijl A., Leske M.C., Bengtsson B., et al. Reduction of intraocular pressure and glaucoma progression. Results from the Early Manifest Glaucoma Trial. Arch Ophthalmol 120 (2002) 1268-1279
23. Leske M.C., Heijl A., Hussein M., et al. Factors for glaucoma progression and the effect of treatment. The Early Manifest Glaucoma Trial. Arch Ophthalmol 121 (2003) 48-56
24. Collaborative Normal Tension Glaucoma Study Group. The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Am J Ophthalmol 126 (1998) 498-505
25. AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol 130 (2000) 429-440
26. Lichter P.R., Musch D.C., Gillespie B.W., et al., CIGTS Study Group. Interim clinical outcome in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medication or surgery. Ophthalmology 108 (2001) 1943-1953
27. Drance S., Anderson D.R., Schulzer M., and Collaborative Normal-Tension Glaucoma Study Group. Risk factors for progression of visual field abnormalities in normal-tension glaucoma. Am J Ophthalmol 131 (2001) 699-708
28. Quigley H.A. European Glaucoma Prevention Study. Ophthalmology 112 (2005) 1642-1643
29. Miglior S., Pfeiffer N., Zeyen T., et al. European Glaucoma Prevention Study. Ophthalmology 112 (2005) 1643-1645
30. Werner E.B., Drance S.M., and Schulzer M. Trabeculectomy and the progression of glaucomatous visual field loss. Arch Ophthalmol 95 (1977) 1374-1377
31. Stewart W.C., Kolker A.E., Sharpe E.D., et al. Factors associated with long-term progression or stability in primary open-angle glaucoma. Am J Ophthalmol 130 (2000) 274-279
32. Niesel P., and Flammer J. Correlations between intraocular pressure, visual field and visual acuity, based on 11 years of observations of treated chronic glaucomas. Int Ophthalmol 3 (1980) 31-35
33. O'Brien C., Schwartz B., Takamoto T., et al. Intraocular pressure and the rate of visual field loss in chronic open-angle glaucoma. Am J Ophthalmol 111 (1991) 491-500
34. Stewart W.C., Chorak R.P., Hunt H.H., et al. Factors associated with visual loss in patients with advanced glaucomatous changes in the optic nerve head. Am J Ophthalmol 116 (1993) 176-181
35. Bergea B., Bodin L., and Svedbergh B. Impact of intraocular pressure regulation on visual fields in - open-angle glaucoma. Ophthalmology 106 (1999) 176-181
36. Asrani S., Zeimer R., Wilensky J., et al. Large diurnal fluctuations in intraocular pressure are an independent risk factor in patients with glaucoma. J Glaucoma 9 (2000) 134-142
37. Bengtsson B., and Heijl A. Diurnal IOP fluctuation: not an independent risk factor for glaucomatous visual field loss in high risk ocular hypertension. Graefe's Arch Clin Exp Ophthalmol 243 (2005) 513-518
38. Bengtsson B., Leske M.C., Hyman L., et al., Early Manifest Glaucoma Trial Group. Fluctuation of intraocular pressure and glaucoma progression in the Early Manifest Glaucoma Trial. Ophthalmology 114 (2007) 205-209
39. Quigley H.A., West S.K., Rodriguez J., et al. The prevalence of glaucoma in a population-based study of Hispanic subjects. Proyecto VER. Arch Ophthalmol 119 (2001) 1819-1826
40. Sehi M., Flanagan J.G., Zeng L., et al. Relative change in diurnal mean ocular perfusion pressure: a risk factor for the diagnosis of primary open-angle glaucoma. Invest Ophthalmol Vis Sci 46 (2005) 4581-4587
41. Flammer J., Orgul S., Costa V.T., et al. The impact of ocular blood flow in glaucoma. Prog Retin Eye Res 21 (2002) 359-393
42. Fuchsjager-Maryl G., Wally B., Georgopoulos M., et al. Ocular blood flow and systemic blood pressure in patients with primary open-angle glaucoma and ocular hypertension. Invest Ophthalmol Vis Sci 45 (2004) 834-839
43. Hayreh S.S., Zimmerman M.B., Podhajsky P., et al. Nocturnal arterial hypotension and its role in optic nerve head and ocular ischemic disorders. Am J Ophthalmol 117 (1994) 603-624
44. Topouzis F., Coleman A.L., Harris A., et al. Association of blood pressure status with the optic disk structure in non-glaucoma subjects: the Thessaloniki Eye Study. Am J Ophthalmol 142 (2006) 60-67